Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
BMJ
    March 2026
  1. CAI M, Choi T, Xie Y, Al-Aly Z, et al
    Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study.
    BMJ. 2026;392:e086886.
    >> Share

    February 2026
  2. WISE J
    New weight loss pill outperforms oral semaglutide for diabetes patients, study reports.
    BMJ. 2026;392:s399.
    >> Share

  3. WISE J
    Type 2 diabetes: SGLT-2 inhibitors should be offered as first line treatment, doctors are told.
    BMJ. 2026;392:s333.
    >> Share

    January 2026
  4. ALLOTEY J, Coomar D, Ensor J, Ruiz-Calvo G, et al
    Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis.
    BMJ. 2026;392:e084159.
    >> Share

    December 2025
  5. O'DOWD A
    Diabetes prevention: Almost a million people access NHS scheme.
    BMJ. 2025;391:r2686.
    >> Share

    November 2025
  6. LOGAN M
    Trump expands visa requirements to include diabetes and obesity.
    BMJ. 2025;391:r2400.
    >> Share

    October 2025
  7. HONG B, Lee H, Jung K, Rhee SY, et al
    Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: population based cohort study.
    BMJ. 2025;391:e085196.
    >> Share

  8. TAYLOR L
    Sixty seconds on . . . type 5 diabetes.
    BMJ. 2025;391:r2092.
    >> Share

    September 2025
  9. MCCRAY BA, Stino AM, Davalos L, Quigley S, et al
    Atypical diabetic neuropathies.
    BMJ. 2025;390:e081109.
    >> Share

  10. FARMER A, Patel K, Dambha-Miller H
    Once weekly insulin in type 2 diabetes.
    BMJ. 2025;390:r1931.
    >> Share

  11. LUCEWICZ SAMARAWICKRAMA A, Pasupathy D
    Preventing gestational diabetes.
    BMJ. 2025;390:r1900.
    >> Share

  12. SUJAN MJ, Skarstad HM, Rosvold G, Fougner SL, et al
    Time restricted eating and exercise training before and during pregnancy for people with increased risk of gestational diabetes: single centre randomised controlled trial (BEFORE THE BEGINNING).
    BMJ. 2025;390:e083398.
    >> Share

  13. TAYLOR L
    WHO adds controversial cancer and diabetes treatments to essential medicines list.
    BMJ. 2025;390:r1881.
    >> Share

    August 2025
  14. BOWIE K
    Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance "shake-up".
    BMJ. 2025;390:r1777.
    >> Share

  15. KAR P
    Partha Kar: The Super Six diabetes care model offers lessons for shifting care into the community.
    BMJ. 2025;390:r1727.
    >> Share

  16. BOWIE K
    Type 1 diabetes: UK approves first drug for delaying onset.
    BMJ. 2025;390:r1762.
    >> Share

  17. THEODORAKI A
    Management of type 2 diabetes.
    BMJ. 2025;390:r1726.
    >> Share

  18. AGARWAL A, Mustafa R, Manja V, Agoritsas T, et al
    Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
    BMJ. 2025;390:e082071.
    >> Share

  19. NONG K, Jeppesen BT, Shi Q, Agoritsas T, et al
    Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.
    BMJ. 2025;390:e083039.
    >> Share

  20. MISRA A, Sattar N, Ghosh A, Nassar M, et al
    Type 2 diabetes in South Asians.
    BMJ. 2025;390:e079801.
    >> Share

  21. IBSEN DB, Zhang Y
    Potatoes and risk of type 2 diabetes.
    BMJ. 2025;390:r1557.
    >> Share

  22. MOUSAVI SM, Gu X, Imamura F, AlEssa HB, et al
    Total and specific potato intake and risk of type 2 diabetes: results from three US cohort studies and a substitution meta-analysis of prospective cohorts.
    BMJ. 2025;390:e082121.
    >> Share

    July 2025
  23. NOLAN T
    Diabetes deprescribing . . . and other research.
    BMJ. 2025;390:r1365.
    >> Share

  24. KOGA H
    Stigmatising language made me avoid diabetes care; meaningful engagement with people with diabetes is the answer.
    BMJ. 2025;390:r981.
    >> Share

    June 2025
  25. KAR P
    Partha Kar: The spending review is an opportunity to reevaluate priorities in diabetes care.
    BMJ. 2025;389:r1175.
    >> Share

  26. LIN J, Huang Y, Xu B, Gu X, et al
    Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial.
    BMJ. 2025;389:e083735.
    >> Share

    April 2025

  27. Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.
    BMJ. 2025;389:r845.
    >> Share

    February 2025
  28. SHAPIRO SB, Yin H, Yu OHY, Rej S, et al
    Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.
    BMJ. 2025;388:e080679.
    >> Share

    January 2025
  29. HOPE D, Valabhji J
    SGLT2 inhibitors and dietary calorie restriction for type 2 diabetes remission.
    BMJ. 2025;388:r40.
    >> Share

  30. LIU Y, Chen Y, Ma J, Lin J, et al
    Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.
    BMJ. 2025;388:e081820.
    >> Share

    December 2024
  31. MOTTELSON M, Helby J, Nordestgaard BG, Ellervik C, et al
    Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study.
    BMJ. 2024;387:e079147.
    >> Share

  32. LIU B, Zong G, Zhu L, Hu Y, et al
    Chocolate intake and risk of type 2 diabetes: prospective cohort studies.
    BMJ. 2024;387:e078386.
    >> Share

    November 2024
  33. IACOBUCCI G
    Diabetes: Global treatment gap is widening, study finds.
    BMJ. 2024;387:q2515.
    >> Share

  34. SCIVIER M
    Quality care is needed for older people with diabetes in care homes-now and for the future.
    BMJ. 2024;387:q2471.
    >> Share

  35. SVANSTROM H, Mkoma GF, Hviid A, Pasternak B, et al
    SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study.
    BMJ. 2024;387:e080925.
    >> Share

    October 2024
  36. MCCORMICK N, Yokose C, Lu N, Wexler DJ, et al
    Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
    BMJ. 2024;387:e080035.
    >> Share

  37. ALKABBANI W, Suissa K, Gu KD, Cromer SJ, et al
    Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study.
    BMJ. 2024;387:e080340.
    >> Share

  38. MENG LC, van Gelder MMHJ, Chuang HM, Chen LK, et al
    Paternal metformin use and risk of congenital malformations in offspring in Norway and Taiwan: population based, cross national cohort study.
    BMJ. 2024;387:e080127.
    >> Share

  39. LIU L, Ke W, Li H, Li F, et al
    Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial.
    BMJ. 2024;387:e080122.
    >> Share

  40. AGARWAL A, Zeng X, Li S, Rayner D, et al
    Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
    BMJ. 2024;387:e080257.
    >> Share

    September 2024
  41. WISE J
    Diabetes: Once weekly insulin could be as effective as daily injections, studies indicate.
    BMJ. 2024;386:q2005.
    >> Share


  42. Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
    BMJ. 2024;386:q1911.
    >> Share

    August 2024
  43. TU SY, Shao SC, Loh CH, Huang HK, et al
    SGLT-2 inhibitors and dementia.
    BMJ. 2024;386:q1841.
    >> Share

  44. MAHASE E
    Semaglutide's CVD indication could cost US Medicare $145bn extra a year.
    BMJ. 2024;386:q1878.
    >> Share

  45. SHIN A, Koo BK, Lee JY, Kang EH, et al
    Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
    BMJ. 2024;386:e079475.
    >> Share

  46. KMIETOWICZ Z
    SGLT-2 inhibitors for diabetes may help prevent dementia, study finds.
    BMJ. 2024;386:q1875.
    >> Share

  47. MAHASE E
    Diabetes: One in 10 patients on NHS's "soups and shakes" diet plan went into remission.
    BMJ. 2024;386:q1733.
    >> Share

    July 2024
  48. MAHASE E
    Semaglutide: FDA publishes warning amid reports of patients overdosing.
    BMJ. 2024;386:q1696.
    >> Share

  49. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    >> Share

  50. MAHASE E
    GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment.
    BMJ. 2024;386:q1645.
    >> Share

  51. LAL N
    India: Doctors report surge in use of off label GLP-1 agonists among rich.
    BMJ. 2024;386:q1605.
    >> Share

  52. DYER C
    People with type 1 diabetes and disordered eating need joined-up care, says coroner after woman's death.
    BMJ. 2024;386:q1597.
    >> Share

  53. VANDERPANT N, Ward E, Farrell E, Theodoraki A, et al
    Insulin for people with type 2 diabetes mellitus.
    BMJ. 2024;386:e078015.
    >> Share

  54. WISE J
    Covid-19: Progression to clinical type 1 diabetes accelerated after infection, study suggests.
    BMJ. 2024;386:q1557.
    >> Share

  55. SETHI J
    Use of language in diabetes: what's in a name?
    BMJ. 2024;386:q1446.
    >> Share

    June 2024
  56. MAHASE E
    GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use.
    BMJ. 2024;385:q1448.
    >> Share

  57. FU EL, Wexler DJ, Cromer SJ, Bykov K, et al
    SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
    BMJ. 2024;385:e078483.
    >> Share

  58. DOBLE E, Farrow D
    We need to tackle the increasing mountain of wasted plastic and cardboard from diabetes technologies.
    BMJ. 2024;385:q1337.
    >> Share

  59. ZHANG J, Li Y
    Increasing prevalence of type 1 diabetes in older age may be a good sign.
    BMJ. 2024;385:q1322.
    >> Share

  60. YANG K, Yang X, Jin C, Ding S, et al
    Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study.
    BMJ. 2024;385:e078432.
    >> Share


  61. New advances in type 1 diabetes.
    BMJ. 2024;385:q1224.
    >> Share

    May 2024
  62. JENKINS AJ, Ogle GD, Scibilia R, Schwarz P, et al
    People who need insulin are particularly vulnerable in disasters and conflicts.
    BMJ. 2024;385:q1109.
    >> Share

  63. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ. 2024;385:e077097.
    >> Share

    April 2024
  64. MAHASE E
    Diabetes UK defends partnership with Slimming World in face of criticism.
    BMJ. 2024;385:q962.
    >> Share

  65. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

  66. NOLAN T
    The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
    BMJ. 2024;385:q859.
    >> Share

  67. SETHI J
    Breaking free from the stigma of diabetes.
    BMJ. 2024;385:q890.
    >> Share

  68. BOKINNI Y
    Barbados is in the grip of a diabetic foot amputation crisis.
    BMJ. 2024;385:q350.
    >> Share

  69. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ. 2024;385:e078225.
    >> Share

    March 2024
  70. CHRISTIE B
    Charity calls for Scottish government to increase access to diabetes technology.
    BMJ. 2024;384:q755.
    >> Share

  71. MAHASE E
    Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
    BMJ. 2024;384:q744.
    >> Share

  72. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  73. TANNE JH
    FDA approves first over-the-counter blood glucose monitor for diabetes.
    BMJ. 2024;384:q611.
    >> Share

  74. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    >> Share

    February 2024
  75. LANE MM, Gamage E, Du S, Ashtree DN, et al
    Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
    BMJ. 2024;384:e077310.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016